Fluconazole - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for fluconazole and what is the scope of freedom to operate?
Fluconazole
is the generic ingredient in eight branded drugs marketed by Pfizer, Aurobindo Pharma, Hainan Poly, Hikma, Ivax Sub Teva Pharms, Sun Pharm Inds Ltd, Taro Pharm Inds, Hikma Farmaceutica, Hospira, Norvium Bioscience, Woodward, Baxter Hlthcare Corp, Dr Reddys, Fresenius Kabi Usa, Baxter Hlthcare, Inforlife, Mylan Labs Ltd, West-ward Pharms Int, Ani Pharms, Chartwell, Dr Reddys Labs Inc, Gedeon Richter Usa, Glenmark Pharms Ltd, Lupin Ltd, Mylan Pharms Inc, Pliva, Ranbaxy Labs Ltd, Roxane, Taro, Teva, Thinq Pharm-cro Pvt, and Zydus Pharms, and is included in forty-five NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-three drug master file entries for fluconazole. Forty-six suppliers are listed for this compound. There are five tentative approvals for this compound.
Summary for fluconazole
US Patents: | 0 |
Tradenames: | 8 |
Applicants: | 32 |
NDAs: | 45 |
Drug Master File Entries: | 23 |
Finished Product Suppliers / Packagers: | 46 |
Raw Ingredient (Bulk) Api Vendors: | 158 |
Clinical Trials: | 274 |
Patent Applications: | 7,103 |
Drug Prices: | Drug price trends for fluconazole |
Drug Sales Revenues: | Drug sales revenues for fluconazole |
What excipients (inactive ingredients) are in fluconazole? | fluconazole excipients list |
DailyMed Link: | fluconazole at DailyMed |
Recent Clinical Trials for fluconazole
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Alexion Pharmaceuticals, Inc. | Phase 1 |
Huashan Hospital | Phase 4 |
FEMPHARMA Kft. | N/A |
Generic filers with tentative approvals for FLUCONAZOLE
Applicant | Application No. | Strength | Dosage Form |
⤷ Sign Up | ⤷ Sign Up | 200MG | TABLET;ORAL |
⤷ Sign Up | ⤷ Sign Up | 150MG | TABLET;ORAL |
⤷ Sign Up | ⤷ Sign Up | 100MG | TABLET;ORAL |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for fluconazole
Drug Class | Azole Antifungal |
Mechanism of Action | Cytochrome P450 2C19 Inhibitors Cytochrome P450 2C9 Inhibitors Cytochrome P450 3A4 Inhibitors |
Medical Subject Heading (MeSH) Categories for fluconazole
Anatomical Therapeutic Chemical (ATC) Classes for fluconazole
US Patents and Regulatory Information for fluconazole
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thinq Pharm-cro Pvt | FLUCONAZOLE | fluconazole | TABLET;ORAL | 076957-003 | Sep 28, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sun Pharm Inds Ltd | FLUCONAZOLE | fluconazole | FOR SUSPENSION;ORAL | 076332-001 | Jul 29, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell | FLUCONAZOLE | fluconazole | TABLET;ORAL | 076665-004 | Jul 29, 2004 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for fluconazole
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | DIFLUCAN | fluconazole | TABLET;ORAL | 019949-004 | Jun 30, 1994 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | DIFLUCAN | fluconazole | TABLET;ORAL | 019949-002 | Jan 29, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | DIFLUCAN | fluconazole | TABLET;ORAL | 019949-001 | Jan 29, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.